Myomo (MYO) EBIT Growth (1y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.06% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 20.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 74.18% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 90.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -18.12% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 46.60% |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -267.34% |
| Jun 30, 2025 | -311.66% |
| Mar 31, 2025 | 9.48% |
| Dec 31, 2024 | 89.92% |
| Sep 30, 2024 | 52.70% |
| Jun 30, 2024 | -1.09% |
| Mar 31, 2024 | -45.59% |
| Dec 31, 2023 | -9.14% |
| Sep 30, 2023 | 28.18% |
| Jun 30, 2023 | 61.91% |
| Mar 31, 2023 | 2.47% |
| Dec 31, 2022 | 17.61% |
| Sep 30, 2022 | -38.83% |
| Jun 30, 2022 | -11.39% |
| Mar 31, 2022 | 6.61% |
| Dec 31, 2021 | -60.42% |
| Sep 30, 2021 | 20.23% |
| Jun 30, 2021 | 8.74% |
| Mar 31, 2021 | 14.32% |
| Dec 31, 2020 | 34.65% |
| Sep 30, 2020 | 9.91% |
| Jun 30, 2020 | -5.25% |
| Mar 31, 2020 | -27.57% |
| Dec 31, 2019 | 5.64% |
| Sep 30, 2019 | -4.31% |
| Jun 30, 2019 | -0.91% |
| Mar 31, 2019 | -11.65% |
| Dec 31, 2018 | -50.61% |
| Sep 30, 2018 | -88.74% |
| Jun 30, 2018 | -38.72% |
| Mar 31, 2018 | -76.21% |
| Dec 31, 2017 | -65.54% |
| Sep 30, 2017 | -53.67% |
| Jun 30, 2017 | -180.79% |